Theodore J. Criares

Array ( [id] => 4096674 [patent_doc_number] => 06096737 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tryptophan and possibly a vitamin B12 compound' [patent_app_type] => 1 [patent_app_number] => 8/817086 [patent_app_country] => US [patent_app_date] => 1997-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1552 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096737.pdf [firstpage_image] =>[orig_patent_app_number] => 817086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550910 [patent_doc_number] => 06399592 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Bishphosphonate/estrogen synergistic therapy for treating and preventing bone loss' [patent_app_type] => B1 [patent_app_number] => 08/880735 [patent_app_country] => US [patent_app_date] => 1997-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2729 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399592.pdf [firstpage_image] =>[orig_patent_app_number] => 08880735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1462861 [patent_doc_number] => 06350752 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Carbon monoxide dependent guanylyl cyclase modifiers and methods of use' [patent_app_type] => B1 [patent_app_number] => 08/878656 [patent_app_country] => US [patent_app_date] => 1997-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 18613 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350752.pdf [firstpage_image] =>[orig_patent_app_number] => 08878656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992329 [patent_doc_number] => 05891863 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices' [patent_app_type] => 1 [patent_app_number] => 8/876898 [patent_app_country] => US [patent_app_date] => 1997-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3019 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891863.pdf [firstpage_image] =>[orig_patent_app_number] => 876898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947650 [patent_doc_number] => 05998485 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Method for modulating immune response with inositol' [patent_app_type] => 1 [patent_app_number] => 8/874470 [patent_app_country] => US [patent_app_date] => 1997-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7814 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998485.pdf [firstpage_image] =>[orig_patent_app_number] => 874470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833756 [patent_doc_number] => 05814649 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Preventive and remedy for type 1 allergic diseases' [patent_app_type] => 1 [patent_app_number] => 8/817241 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4182 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814649.pdf [firstpage_image] =>[orig_patent_app_number] => 817241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410311 [patent_doc_number] => 06265443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Method for treating neuronal injury with carboxyfullerene' [patent_app_type] => 1 [patent_app_number] => 8/867378 [patent_app_country] => US [patent_app_date] => 1997-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 7884 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265443.pdf [firstpage_image] =>[orig_patent_app_number] => 867378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4001424 [patent_doc_number] => 05888514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Natural composition for treating bone or joint inflammation' [patent_app_type] => 1 [patent_app_number] => 8/862513 [patent_app_country] => US [patent_app_date] => 1997-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3982 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888514.pdf [firstpage_image] =>[orig_patent_app_number] => 862513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046045 [patent_doc_number] => 05908848 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Synergistic composition of codine and ibuprofen to treat arthritis' [patent_app_type] => 1 [patent_app_number] => 8/855848 [patent_app_country] => US [patent_app_date] => 1997-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 3506 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908848.pdf [firstpage_image] =>[orig_patent_app_number] => 855848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994914 [patent_doc_number] => 05919823 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Treatment of secondary movement disorders using large neutral amino acids' [patent_app_type] => 1 [patent_app_number] => 8/854095 [patent_app_country] => US [patent_app_date] => 1997-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12121 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919823.pdf [firstpage_image] =>[orig_patent_app_number] => 854095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048870 [patent_doc_number] => 05968936 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Methods for treating or preventing Alzheimer\'s Disease using substituted 1-aryl-3-morpholinopropanones' [patent_app_type] => 1 [patent_app_number] => 8/844737 [patent_app_country] => US [patent_app_date] => 1997-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 12310 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968936.pdf [firstpage_image] =>[orig_patent_app_number] => 844737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235476 [patent_doc_number] => 06075026 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Certain substituted 1-aryl-3-piperazin-1\'-yl propanones' [patent_app_type] => 1 [patent_app_number] => 8/837598 [patent_app_country] => US [patent_app_date] => 1997-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 22203 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075026.pdf [firstpage_image] =>[orig_patent_app_number] => 837598 [rel_patent_id] =>[rel_patent_doc_number] =>)